Business Wire

EVER Pharma Launches a Digital Training App for the D- mine ® Pump

Share

After successfully launching the D-mine® Pump, an infusion device designed to provide precise continuous subcutaneous drug delivery for Parkinson´s patients, EVER Pharma developed an App to support the training needs of Healthcare Professionals and caregivers.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220712005103/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

The digital Training App for the D-mine® Pump supporting the training needs (Graphic: Business Wire)

EVER Pharma, a specialist in neurological diseases, offers a complete therapy package for Parkinson’s disease with D-mine® Pump, D-mine® Pen and Dacepton® (Dopaceptin®, Apomorphine hydrochloride) and with its new D-mine® Pump TRAINING APP a simulation tool to support the training and the programing of the D-mine® Pump.

The App can be easily downloaded and installed onto Android or iOS devices by Healthcare Professionals or caregivers who are working with the D-mine® Pump and managing the therapy of Parkinson´s patients with infusion therapy.

“With the development of the TRAINING APP for the D-mine® Pump in Parkinson's therapy, we now have an empowering and interactive tool to support the training of the Healthcare Professionals and caregivers on how to use and program the infusion pump device. The App is an intuitive, easy-to-use simulator and enables training any time everywhere”, explains Georges Kahwati, General Manager at EVER Pharma GmbH.

For more information please visit www.d-minecare.com.

About EVER Pharma GmbH

EVER Pharma is a fully integrated specialty pharmaceuticals company focused on the research, development, production and commercialization of products in the areas of neurology, critical care, anesthesia and oncology.

From its global headquarters in Austria, Ever Pharma provides innovative therapies and value-added formulations aimed at enhancing patient and healthcare professional’s lives through improved safety and convenience.

The products are developed and manufactured at EU GMP certified facilities in Austria and Germany. The technical operations are highly specialized in the production of complex injectables including high potency substances, crystal suspensions, oily solutions and controlled substances in vials, pre-filled syringes, cartridges, ampoules and implants. EVER markets its products in more than 80 countries around the world through 30 international affiliated companies and strategic partners.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Contact Press
Marie-Kristin Schöppl
International Marketing Manager
Phone: +43 7665 20555 530
E-Mail: marie-kristin.schoeppl@everpharma.com
www.everpharma.com
www.d-minecare.com

Contact Partner/Investor Relations
Dominic Benning
Head of Dopaminergic Therapy
Phone: +43 7665 20555 861
E-Mail: dominic.benning@everpharma.com

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

China's 2024 Labor Day Sees 77% Rise in Outbound Travel Transactions and 700% Surge in Inbound Spending YoY via Alipay5.5.2024 16:29:00 CEST | Press release

Alipay's data indicates a significant uptick in both outbound and inbound tourism spending in China during the 2024 Labor Day holiday. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240505795104/en/ The salesperson welcomes Chinese travelers to use Alipay for payment at Designer Outlet Roermond in the Netherlands (Photo: Business Wire) Outbound Tourism Transactions by Alipay users in overseas markets during the initial two days of the holiday saw a substantial 77% increase from the corresponding period in 2023, with total spending rising by 10% year-on-year. For the 2024 Labor Day holiday, Alipay, an Alipay+ partner wallet, has joined hands with global merchants to launch extensive campaigns aimed at enticing Chinese tourists. Enabled by Alipay+, a suite of cross-border digital payment and digitalization technology solutions connecting global brands with mobile-savvy consumers worldwide, Chinese travelers can seamlessly pay

MOGAS Mourns the Death of Their Beloved Chairman and Founder Vincent Louis Mogas3.5.2024 19:30:00 CEST | Press release

MOGAS mourns the death of their beloved chairman and founder Vincent Louis Mogas, who died on May 2, 2024 in Houston, Texas. Louis spent his life building a valve manufacturing business and a company culture that stood for goodness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240503919754/en/ V. Louis Mogas, Founder and Chairman of MOGAS Industries (1939 - 2024) (Photo: MOGAS Industries Inc.) MOGAS Industries was formed in May 1973 when Louis Mogas purchased a small machine shop in Houston. He soon acquired the rights to service and manufacture ball valves from Cameron Iron Works. Under Louis' leadership, the Company studied valve failures and established an R&D department that customized valves for specific applications. Since 2000, MOGAS has established sales and service offices in Australia, China, Europe, Canada, South America, Middle East and India. Early on, Louis Mogas introduced business behaviors that became the

Ververica Achieves ISO 27001 Certification, Bolstering Data Security3.5.2024 18:08:00 CEST | Press release

Ververica, a comprehensive streaming data platform provider, announces the achievement of ISO 27001 certification, a significant milestone in its commitment to data security and governance. This certification is internationally recognized as the gold standard for information security management systems (ISMS), and demonstrates the company’s commitment to protecting sensitive corporate and customer data against emerging cyber threats. For Ververica and its customers, this ensures that data is managed under the strictest security protocols, enhancing trust and confidence in Ververica’s ability to handle sensitive information securely and effectively. Ververica's security operations utilize Vanta, a trusted third-party management platform, for rigorous real-time monitoring and security alerts. To further enhance transparency and customer trust, Ververica has introduced a dedicated Trust Center webpage where stakeholders and potential customers can review live detailed information about se

Lone Star Announces Acquisition of ERIKS3.5.2024 15:07:00 CEST | Press release

Lone Star Funds (“Lone Star”) today announced that an affiliate has acquired ERIKS N.V., a specialized pan-European industrial components distributor and engineering service provider. Financial terms of the transaction were not disclosed. Founded in 1940, ERIKS has established itself as a European leader in specialized industrial services with over 200 locations in 12 countries. ERIKS’ deep industry experience, technical knowledge, local distribution network and dedicated engineering facilities allow it to develop advanced, customized solutions that drive performance improvements, deliver cost savings and add measurable technical and commercial value for its customers. Donald Quintin, Chief Executive Officer and Global President of Lone Star, said, "ERIKS represents an exciting investment opportunity and a valuable addition to our European investment portfolio. This acquisition aligns with our strategy of investing in market leading businesses that exhibit both growth and operating imp

Mars, Incorporated Enters Exclusive Discussions to Acquire the Entire Stake in French Veterinary Diagnostics Businesses Cerba Vet and ANTAGENE Held by the Cerba HealthCare Group3.5.2024 15:00:00 CEST | Press release

Mars, Incorporated today announced that it has entered into exclusive discussions with Cerba HealthCare with a view to acquiring Cerba HealthCare’s ownership stake in Cerba Vet and ANTAGENE. Headquartered in Massy, France, Cerba Vet is a network of six veterinary diagnostics laboratories in France and Switzerland. With approximately 140 Associates, Cerba Vet provides full animal-related service diagnostics with complete clinical and anatomic pathology testing as well as endocrinology, microbiology, serology, hematology, chemistry, and other advanced tests, to veterinary practitioners. Cerba Vet is recognized by veterinarians in France for its medical expertise and pioneering continuous education program, the Cerba Vet College, with weekly live webinars and several practical sessions annually. Headquartered in Lyon, France, ANTAGENE is a leading player in animal genetics in Europe, recognised for its expertise in DNA testing for dogs, cats, horses and wildlife. ANTAGENE offers tests glo

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye